AAV6 vector production and purification for muscle gene therapy

CL Halbert, JM Allen, JS Chamberlain - Duchenne muscular dystrophy …, 2018 - Springer
CL Halbert, JM Allen, JS Chamberlain
Duchenne muscular dystrophy: methods and protocols, 2018Springer
Vectors derived from adeno-associated viruses (AAV) have been generated using
numerous naturally occurring and synthetic serotypes of the virus. Such vectors have proven
to be extremely useful for a variety of gene transfer studies, both in vitro and in vivo, and are
increasingly being used in gene therapy protocols for a variety of human disorders. Methods
to produce AAV vectors typically rely on co-transfection of several different plasmid vectors
that carry the transgene of interest (the gene to be delivered, in a “transfer plasmid”) and …
Abstract
Vectors derived from adeno-associated viruses (AAV) have been generated using numerous naturally occurring and synthetic serotypes of the virus. Such vectors have proven to be extremely useful for a variety of gene transfer studies, both in vitro and in vivo, and are increasingly being used in gene therapy protocols for a variety of human disorders. Methods to produce AAV vectors typically rely on co-transfection of several different plasmid vectors that carry the transgene of interest (the gene to be delivered , in a “transfer plasmid”) and helper genes needed for AAV vector replication and packaging (helper plasmids). While the methods used to generate AAV are conceptually simple, minor variations in a variety of steps can result in significant differences in the overall yield of vector. Here we describe protocols for generating vectors derived from AAV6, which are particularly useful for gene transfer to muscle tissues.
Springer